Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR
· Real-Time Price · USD
35.87
0.01 (0.03%)
At close: Aug 15, 2025, 3:59 PM
35.71
-0.45%
After-hours: Aug 15, 2025, 04:10 PM EDT
Monopar Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -3.25B | -17.66M | -16.16M | -7M | -7.49M | -8.03M | -8.83M | -9.83M | -10.17M | -10.6M | -10.54M | -10.31M | -10.36M | -9.69M | -9.13M | -8.71M | -7.9M | -7.27M |
Interest Income | 781.61M | 918.7K | 404.02K | 353.06K | 365.97K | 420.72K | 429.04K | 343.63K | 239.06K | 111.26K | 21.24K | 9.1K | 1.98K | 13.79K | 24.02K | 33.4K | 41.37K | 47.46K |
Pretax Income | -3.77B | -1.32B | -1.32B | -1.31B | -7.12M | -7.61M | -8.4M | -9.48M | -9.93M | -10.49M | -10.52M | -10.3M | -10.36M | -9.68M | -9.1M | -8.55M | -7.73M | -7.1M |
Net Income | -3.77B | -1.32B | -1.32B | -1.31B | -7.12M | -7.61M | -8.31M | -9.38M | -9.83M | -10.39M | -10.5M | -10.3M | -10.36M | -9.68M | -9.1M | -8.55M | -7.73M | -7.1M |
Selling & General & Admin | 1.51B | 3.98M | 3.16M | 2.88M | 3.04M | 3.12M | 3.23M | 3.16M | 3.09M | 3.04M | 2.95M | 2.84M | 2.79M | 2.73M | 2.63M | 2.56M | 2.32M | 2.34M |
Research & Development | 1.74B | 13.68M | 13.01M | 4.12M | 4.45M | 4.91M | 5.6M | 6.67M | 7.08M | 7.57M | 7.59M | 7.47M | 7.57M | 6.96M | 6.49M | 6.14M | 5.57M | 4.93M |
Other Expenses | 632.00 | 826.00 | -123 | -496 | -1.07K | -1.26K | -871 | -474 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 3.25B | 17.66M | 16.16M | 7M | 7.49M | 8.03M | 8.83M | 9.83M | 10.17M | 10.6M | 10.54M | 10.31M | 10.36M | 9.69M | 9.13M | 8.71M | 7.9M | 7.27M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | -590.03M | -590.03M | -590.03M | -590.03M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 15.87M | 17.66M | 16.16M | 7M | 7.49M | 8.03M | 8.83M | 9.83M | 10.17M | 10.6M | 10.54M | 10.31M | 10.36M | 9.69M | 9.13M | 8.71M | 7.9M | 7.27M |
Income Tax Expense | n/a | n/a | n/a | -1.91K | -1.91K | -1.91K | -92.4K | -104.03K | -104.03K | -104.86K | -15.3K | -2.81K | -2.81K | -1.98K | -1.05K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 7M | 6.91M | 37.9M | 3.52M | 3.5M | 15.98M | 14.9M | 14.12M | 13.42M | 13.11M | 12.95M | 12.76M | 12.63M | 12.6M | 12.58M | 12.58M | 12.57M | 12.14M |
Shares Outstanding (Diluted) | 7M | 6.99M | 37.9M | 3.52M | 3.5M | 15.98M | 14.9M | 14.12M | 13.42M | 13.11M | 12.95M | 12.76M | 12.63M | 12.6M | 12.58M | 12.58M | 12.57M | 12.14M |
EPS (Basic) | -1.39 | -1.53 | -1.25 | -1.08 | -0.85 | -0.52 | -0.6 | -0.7 | -0.75 | -0.81 | -0.82 | -0.81 | -0.82 | -0.77 | -0.74 | -0.72 | -0.67 | -0.64 |
EPS (Diluted) | -1.39 | -1.53 | -1.25 | -1.08 | -0.85 | -0.52 | -0.6 | -0.7 | -0.75 | -0.81 | -0.82 | -0.81 | -0.82 | -0.77 | -0.74 | -0.72 | -0.67 | -0.64 |
EBITDA | -3.25B | -16.23M | -14.3M | -5.62M | -6.43M | -7.39M | -8.62M | -9.72M | -10.17M | -10.6M | -10.54M | -10.31M | -10.36M | -9.69M | -9.13M | -8.71M | -7.9M | -7.27M |
EBIT | -15.45M | -17.17M | -15.59M | -6.47M | -7.12M | -7.61M | -8.4M | -9.48M | -9.93M | -10.49M | -10.52M | -10.3M | -10.36M | -9.68M | -9.1M | -8.55M | -7.73M | -7.1M |
Depreciation & Amortization | 15.87M | 17.66M | 16.16M | 5.09M | 3.51M | 4.05M | 4.85M | 7.76M | 10.17M | 10.6M | 10.54M | 10.31M | 10.36M | 9.69M | 9.13M | 8.71M | 7.9M | 7.27M |